Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AEDs will be replaced by Cardiac Science

This article was originally published in The Silver Sheet

Executive Summary

Cardiac Science will replace about 24,000 automated external defibrillators (AEDs) used by first responders and certain medical facilities under an updated recall plan. The firm announced July 19 that it reached an agreement with FDA to swap potentially dysfunctional AEDs used by police, fire and ambulance workers, as well as hospitals, medical clinics, assisted living facilities and dialysis centers. Cardiac Science issued the field correction for its Powerheart and CardioVive AEDs in November 2009 after discovering the devices may fail to deliver therapy during a resuscitation attempt. The recall - which was classified as Class I by FDA in March - also included AEDs manufactured by Cardiac Science for GE Healthcare and Japan-based Nihon Kohden
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT036506

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel